Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus have?

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus has 232 citations in the OpenAlex counts ScholarIQ stores.

When was Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus published?

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus has 2008 year in the ScholarIQ index.

What is the open-access status of Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus has closed oa status in the ScholarIQ index.

What is the DOI of Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?

The DOI for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is on the source record.

What is the PMID of Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?

The PMID for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is on the source record.

What is the OpenAlex record for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?

The OpenAlex for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is on the source record.